Our portfolio

InspectT

Enabling a new dimension in chemical analysis, InspectT develops and commercializes patented Optical-DOSY technology that adds size sensitivity to standard optical spectrometers, such as IR, UV/Vis, and Raman, without requiring instrument modification. This innovation fills a critical gap in R&D workflows across academia and industry, offering a cost-effective, non-invasive, and user-friendly alternative to traditional, often expensive and complex, size- and chemical-sensitive methods like NMR-DOSY or chromatography. The technology holds significant promise for accelerating innovation in pharmaceuticals, nanotechnology, and environmental reasearch.

Industry: Chemistry, Nanomaterials, Optics

Want to get in contact about InspectT?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Nasim Tavakoli

Physics, Quantum & Chemistry

Our portfolio

Check out similar ventures

Developing local gene therapy for chronic diseases, Arthrogen utilizes viral-mediated gene transfer to treat conditions like rheumatoid arthritis.
Amplifying treatment of chronic autoimmune diseases.

OpticsFoundry

Revolutionizing optical circuit manufacturing by offering robotically assembled and modular optical circuit boards that are easy to design, order, and deploy.
Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.
Developing local gene therapy for chronic diseases, Arthrogen utilizes viral-mediated gene transfer to treat conditions like rheumatoid arthritis.
Amplifying treatment of chronic autoimmune diseases.

OpticsFoundry

Revolutionizing optical circuit manufacturing by offering robotically assembled and modular optical circuit boards that are easy to design, order, and deploy.
Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.